Art
J-GLOBAL ID：201902212041190155   Reference number：19S0464844

Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: A randomized, open-label, phase III, non-inferiority study

  • Publisher site Copy service
  • Access JDreamⅢ for advanced search and analysis.
Author (6)：
Araki, E.

About Araki, E.

(Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University)

About Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University

, 
Inagaki, N.

About Inagaki, N.

(Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine)

About Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine

, 
Tanizawa, Y.

About Tanizawa, Y.

(Division of Endocrinology, Metabolism, Hematological Science and Therapeutics, Yamaguchi University Graduate School of Medicine)

About Division of Endocrinology, Metabolism, Hematological Science and Therapeutics, Yamaguchi University Graduate School of Medicine

, 
Oura, T.

About Oura, T.

(Eli Lilly Japan K.K.)

About Eli Lilly Japan K.K.

, 
Takeuchi, M.

About Takeuchi, M.

(Eli Lilly Japan K.K.)

About Eli Lilly Japan K.K.

, 
Imaoka, T.

About Imaoka, T.

(Eli Lilly Japan K.K.)

About Eli Lilly Japan K.K.


Material：
Diabetes, Obesity and Metabolism

About Diabetes, Obesity and Metabolism


Volume： 17  Issue： 10  Page： 994-1002  Publication year： 2015 
JST Material Number： SCOPUS  ISSN： 1462-8902  CODEN： DOMEF 
Country of issue： United Kingdom (GBR)  Language： English (EN)

Return to Previous Page

TOP

BOTTOM